Disitamab vedotin: a novel antibody-drug conjugates for cancer therapy

Human epidermal growth factor receptor 2 (HER2) regulates cell mitosis, proliferation, and apoptosis. Trastuzumab is a HER2-targeted monoclonal antibody (mAB), which can prolong the overall survival rate of patients with HER2 overexpression in later periods of gastric cancer and breast cancer. Altho...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Fan, Liu, Yanli, Zhou, Xuexiao, Shen, Pei, Xue, Ran, Zhang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090390/
https://www.ncbi.nlm.nih.gov/pubmed/35506447
http://dx.doi.org/10.1080/10717544.2022.2069883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090390/
https://www.ncbi.nlm.nih.gov/pubmed/35506447
http://dx.doi.org/10.1080/10717544.2022.2069883

Ejemplares similares